CAS 248282-07-7: Laquinimod sodium
Formula:C19H17ClN2O3·Na
InChI:InChI=1S/C19H17ClN2O3.Na/c1-3-22(12-8-5-4-6-9-12)19(25)16-17(23)15-13(20)10-7-11-14(15)21(2)18(16)24;/h4-11,23H,3H2,1-2H3;
InChI key:InChIKey=AHIFNCNCUYJCOR-UHFFFAOYSA-N
SMILES:OC=1C=2C(N(C)C(=O)C1C(N(CC)C3=CC=CC=C3)=O)=CC=CC2Cl.[Na]
Synonyms:- N-Ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide sodium salt
- 3-Quinolinecarboxamide, 5-chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-, sodium salt (1:1)
- 3-Quinolinecarboxamide, 5-chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-, sodium salt
- Laquinimod sodium
- ABR 215062 sodium
Sort by
Found 5 products.
3-Quinolinecarboxamide, 5-chloro-N-ethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-N-phenyl-, sodium salt (1:1)
CAS:Formula:C19H17ClN2NaO3Molecular weight:379.7926Laquinimod Sodium Salt
CAS:Laquinimod is a quinoline derivative that is used as a pharmaceutical preparation. It has been shown to be a potent inhibitor of the cb1 receptor, which is responsible for the inflammatory response. Laquinimod also inhibits the phosphorylation of focal adhesion kinase (FAK) and prostaglandin E2 production in mice with colitis. The drug has been shown to have anti-inflammatory effects in several animal models of inflammatory diseases, such as collagen-induced arthritis, experimental autoimmune encephalomyelitis (EAE), or chronic granulomatous disease.Formula:C19H16ClN2NaO3Purity:Min. 95%Molecular weight:378.78 g/molRef: 3D-FL159548
Discontinued productLaquinimod sodium
CAS:Laquinimod (ABR-215062) sodium is an oral agent for MS, halting neurodegeneration and inflammation.Formula:C19H16ClN2NaO3Color and Shape:SolidMolecular weight:378.79Laquinimod Sodium Salt
CAS:Controlled ProductFormula:C19H16ClN2O3·NaColor and Shape:NeatMolecular weight:378.785
